F-star Therapeutics, Inc.
FSTXDelisted Mar 9, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001566373
F-star Therapeutics, Inc. was delisted on Mar 9, 2023; its insiders filed their last Form 4 on Mar 9, 2023; 59 institutions reported holding it in 13F filings for Q4 2022, worth $57.8M in total; Fairfax Financial was the only superinvestor holding it.
13F holders, Q4 2021
Institutional positions in F-star Therapeutics, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 43
- +6 vs. Q3 2021
- Shares held
- 10.6M
- +780.4K (+7.9%) vs. Q3 2021
- Total value
- $53.2M
- −$18.6M (−25.9%) vs. Q3 2021
- New holders
- 11
- 12 more added
- Sold out
- 5
- 6 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting FSTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 59 | $57.8M |
| Q3 2022 | 54 | $35.5M |
| Q2 2022 | 53 | $45.1M |
| Q1 2022 | 40 | $29.0M |
| Q4 2021 | 43 | $53.2M |
| Q3 2021 | 37 | $71.9M |
| Q2 2021 | 41 | $93.5M |
| Q1 2021 | 26 | $19.4M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding F-star Therapeutics, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ridgeback Capital Investments L.P. | 1,834,360 | $9.21M | 5.02% | +1,834,360 | New |
| Point72 Asset Management, L.P. | 981,249 | $4.93M | 0.02% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 900,000 | $4.52M | 0.01% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 858,095 | $4.31M | 0.00% | +34,713+4.2% | Added |
| Rock Springs Capital Management LP | 751,889 | $3.77M | 0.09% | −302,343−28.7% | Reduced |
| Vanguard Group Inc | 747,700 | $3.75M | 0.00% | +3,077+0.4% | Added |
| DAFNA Capital Management LLC | 693,785 | $3.48M | 0.88% | 00.0% | Unchanged |
| Atlas Venture Life Science Advisors, LLC | 599,524 | $3.01M | 0.28% | +599,524 | New |
| Atlas Venture Advisors, Inc. | 574,996 | $2.89M | 0.40% | 00.0% | Unchanged |
| Janus Henderson Group PLC | 522,158 | $2.63M | 0.00% | −156,233−23.0% | Reduced |
| Anson Funds Management LP | 309,703 | $1.55M | 0.21% | +309,703 | New |
| BlackRock Inc. | 291,171 | $1.46M | 0.00% | +1,783+0.6% | Added |
| Renaissance Technologies LLC | 289,411 | $1.45M | 0.00% | +170,000+142.4% | Added |
| Citadel Advisors LLC | 274,100 | $1.38M | 0.00% | +14,455+5.6% | Added |
| Russell Investments Group, Ltd. | 245,077 | $1.23M | 0.00% | +67,791+38.2% | Added |
| Geode Capital Management, LLC | 145,431 | $730.0K | 0.00% | 00.0% | Unchanged |
| Truist Financial Corp | 79,092 | $397.0K | 0.00% | 00.0% | Unchanged |
| TD Asset Management Inc | 58,487 | $294.0K | 0.00% | 00.0% | Unchanged |
| Connolly Sarah T. | 53,001 | $266.0K | 0.15% | 00.0% | Unchanged |
| Eversept Partners, LP | 49,933 | $250.7K | 0.02% | 00.0% | Unchanged |
| State Street Corp | 45,970 | $231.0K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 45,752 | $230.0K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 45,320 | $228.0K | 0.00% | +29,773+191.5% | Added |
| Northern Trust Corp | 35,102 | $176.0K | 0.00% | −57−0.2% | Reduced |
| Jump Financial, LLC | 24,400 | $122.0K | 0.01% | +24,400 | New |
| Parsons Capital Management Inc | 21,879 | $110.0K | 0.01% | −1,725−7.3% | Reduced |
| Morgan Stanley | 18,849 | $95.0K | 0.00% | +9,972+112.3% | Added |
| Susquehanna International Group, LLP | 14,251 | $72.0K | 0.00% | +14,251 | New |
| Private Capital Advisors, Inc. | 13,083 | $66.0K | 0.01% | 00.0% | Unchanged |
| Silvercrest Asset Management Group LLC | 12,585 | $63.0K | 0.00% | −250−1.9% | Reduced |
| Tower Research Capital LLC (TRC) | 10,745 | $54.0K | 0.00% | +10,574+6,183.6% | Added |
| Engineers Gate Manager LP | 10,700 | $54.0K | 0.00% | +10,700 | New |
| ExodusPoint Capital Management, LP | 10,854 | $54.0K | 0.00% | +10,854 | New |
| Bryn Mawr Trust Co | 10,000 | $50.0K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 8,444 | $42.0K | 0.00% | +8,444 | New |
| Cubist Systematic Strategies, LLC | 5,862 | $29.0K | 0.00% | +5,862 | New |
| Total Clarity Wealth Management, Inc. | 3,500 | $18.0K | 0.01% | +3,000+600.0% | Added |
| Arcadia Investment Management Corp | 3,000 | $15.0K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 2,366 | $11.0K | 0.00% | +2,366 | New |
| Advisor Group Holdings, Inc. | 1,049 | $5.00K | 0.00% | +21+2.0% | Added |
| UBS Group AG | 239 | $1.00K | 0.00% | −271−53.1% | Reduced |
| Wells Fargo & Company | 116 | $1.00K | 0.00% | +7+6.4% | Added |
| TCI Wealth Advisors, Inc. | 200 | $1.00K | 0.00% | +200 | New |
| Boxer Capital, LLC | 0 | $0 | 0.00% | −1,751,428−100.0% | Sold out |
| Monashee Investment Management LLC | 0 | $0 | 0.00% | −170,000−100.0% | Sold out |
| Novo Holdings A/S | 0 | $0 | 0.00% | −2,703−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −264−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −200−100.0% | Sold out |